Skip to main content
. 2019 May 16;10:2195. doi: 10.1038/s41467-019-10182-4

Fig. 1.

Fig. 1

Schematic representation of Cys-BOOST. The workflow is exemplified for SNO analysis of untreated (n = 3) and GSNO-treated (n = 3) HeLa cell extracts. Cys-BOOST incorporates the following steps: (1) irreversible blocking of all free thiols with IAA, (2) switch of specifically reduced Cys with alkyne-derivatized iodoacetamide reagent (IAA-alkyne), (3) reduction and alkylation of the remaining (endogenously) oxidized Cys, (4) protein digestion with trypsin, (5) TMT 10plex™ labeling of Lys residues and N-termini for multiplexed quantitative analysis, (6) conjugation of the Dde-biotin-azide linker to IAA-alkyne labeled peptides via copper(I)-catalyzed alkyne-azide cycloaddition (CuAAC), (7) affinity binding of the Cys peptides to streptavidin beads via the biotin group of the Dde-biotin-azide linker, (8) release of the target peptides with 2% hydrazine by single step mild chemical cleavage of the Dde bond, (9) on-tip pH 10 fractionation of the eluate before (10) LC-MS/MS analysis